Related Experiment Video
Updated: Dec 7, 2025
07:32
Standardized Histomorphometric Evaluation of Osteoarthritis in a Surgical Mouse Model
Published on: May 6, 2020
12.8K
Setting up distinctive outcome measures for each osteoarthritis phenotype
Jorge A Roman-Blas1, Lenny A Mendoza-Torres2, Raquel Largo3
1Joint and Bone Research Unit, IIS-Fundacion Jimenez Diaz, UAM, Av. Reyes Catolicos 2, Madrid, 28040, Spain.
Therapeutic Advances in Musculoskeletal Disease
|September 25, 2020
Summary
Osteoarthritis phenotyping is crucial for understanding disease heterogeneity and developing targeted treatments. Differentiating osteoarthritis endotypes and phenotypes enables better patient stratification for clinical trials and personalized therapies.
Area of Science:
- Rheumatology
- Orthopedics
- Translational Medicine
Background:
- Osteoarthritis (OA) is a complex, chronic joint disease with significant global health implications.
- The high heterogeneity in OA's clinical course and etiopathogenesis necessitates better classification methods.
- Current treatment strategies often yield inconclusive results, highlighting the need for refined approaches.
Purpose of the Study:
- To propose a framework for osteoarthritis phenotyping based on underlying pathophysiological mechanisms.
- To emphasize the importance of discriminating between OA endotypes and clinical phenotypes, particularly in early disease stages.
- To advocate for patient stratification using phenotyping for improved clinical trial design and therapeutic discovery.
Main Methods:
- Assessment of OA phenotypes using outcome measures linked to specific pathophysiological mechanisms.
- Analysis of the relationship between distinct OA phenotypes and clinically meaningful outcomes.
- Review of existing clinical trial data and therapeutic approaches for OA.
Main Results:
- Proposed OA phenotyping allows for the identification of distinct patient subgroups.
- Linking phenotypes to specific pathophysiological mechanisms can predict differential clinical outcomes.
- Effective phenotyping is essential for advancing precision medicine in OA treatment.
Conclusions:
- Osteoarthritis phenotyping is vital for addressing disease heterogeneity and improving treatment efficacy.
- This approach facilitates patient stratification, leading to more robust clinical trials.
- Further research and dedicated efforts in OA phenotyping are required to discover precise therapeutic strategies.
